A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression.

NPJ Vaccines · 2024 · PMC10838333 · PMID 38310094

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Serum HBV DNA copies were significantly reduced in mice receiving 10 μg mRNA vaccine and showed a trend of decrease in the 5 μg dosing group (Fig. 2d ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.